American Well Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
38.6%projected annual EPS growth
Analyst Coverage
5analysts covering
FY EPS (est.)
-$2.68next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Amwell Medical Group (AMG) Paid Visits Quarterly382KTarget: 1,320,000 to 1,370,000 visits for FY 2026
Average Revenue Per Visit (ARPV) Quarterly76.0
Subscription Revenue Mix Quarterly0.5Target: Sustained expansion of high-margin SaaS offerings
Watch Items
- Defense Health Agency (DHA) Contract RenewalTrigger: Base contract renewal expected to close around late Q2 or early July 2026Action: Monitor official SEC filings and press releases for confirmation of the DHA base renewal and potential expansion decisions.
- Operating Cash Flow BreakevenTrigger: Targeting positive operating cash flow by Q4 2026Action: Track quarterly cash burn rates (which improved to $3.1 million in Q1 2026) and operating cash outflows to ensure alignment with the year-end breakeven goal.
- Customer Concentration RiskTrigger: Two clients representing 42% and 16% of total Q1 2026 revenueAction: Evaluate pipeline expansion and new contract wins in the government and large payer segments to diversify the revenue base.
Research as of 19 Jun 2026